Estee Lauder (EL) Form 4: RSUs and 44,170 options granted to Rashida La Lande
Rhea-AI Filing Summary
The filing reports insider equity awards for Rashida La Lande, Executive Vice President & General Counsel of The Estée Lauder Companies Inc. (EL). On 08/28/2025 Ms. La Lande was awarded 11,487 restricted stock units (RSUs) vesting in three equal installments beginning 11/02/2026, 11,388 non-annual RSUs vesting on 11/01/2027, and stock options covering 44,170 shares with exercise price $91.77 that vest in three tranches beginning 11/02/2026 and expire 08/28/2035. RSUs pay out one-for-one in Class A common shares and include cash dividend equivalents; shares may be withheld for taxes. The Form 4 was signed by attorney-in-fact on 09/02/2025.
Positive
- Detailed disclosure of awards including exact grant sizes, vesting dates, and exercise price ($91.77) provides transparency for investors
- Mix of RSUs and options creates multi-year alignment between the executive and shareholders through deferred equity
Negative
- Potential dilution from 67,045 total new equity awards (RSUs plus options) if fully vested and issued
- Concentration of vesting in 2026–2028 could lead to clustered share issuance and related expense recognition over a short window
Insights
TL;DR: Routine executive equity awards disclosed; schedules and tax-withholding mechanics are specified.
The Form 4 documents standard long-term incentive grants to a senior executive: two RSU awards and stock options with multi-year vesting schedules. The filing clearly states vesting dates, one-for-one share payout mechanics, dividend equivalents for RSUs, and the option exercise price of $91.77. From a governance perspective, the disclosure meets Section 16 requirements and provides sufficient detail for shareholders to assess timing and potential dilution.
TL;DR: Award composition mixes time-based RSUs and long-dated options consistent with retention and performance alignment.
The award breakdown—11,487 annual RSUs (vested across 2026–2028), 11,388 non-annual RSUs (vest 11/01/2027), and 44,170 options exercisable from 2026–2028 through 2035—indicates a multi-year retention focus. The explicit exercise price of $91.77 and the stated payout and withholding terms give clear metrics for future expense recognition and potential share issuance upon vesting/exercise.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Stock Units (Share Payout) | 11,487 | $0.00 | -- |
| Grant/Award | Restricted Stock Units (Share Payout) | 11,388 | $0.00 | -- |
| Grant/Award | Stock Option (Right to Buy) | 44,170 | $0.00 | -- |
Footnotes (1)
- RSUs vest and are paid out in shares of Class A Common Stock on a one-to-one basis on the applicable vesting date. RSUs generally vest in three approximately equal installments unless otherwise indicated. Upon payout, shares are withheld to cover statutory tax obligations. RSUs are accompanied by dividend equivalent rights payable in cash at the time of the payout of the related shares. Not applicable. Annual RSUs granted August 28, 2025. Assuming continued employment, these RSUs will vest and be paid out as follows: 3,829 on November 2, 2026; 3,829 on November 1, 2027; and 3,829 on November 1, 2028. Non-Annual RSUs granted August 28, 2025. Assuming continued employment, these RSUs will vest and be paid out on November 1, 2027. Stock options granted pursuant to The Estee Lauder Companies Inc. Amended and Restated Fiscal 2002 Share Incentive Plan in respect of: 14,723 shares exercisable from and after November 2, 2026; 14,723 shares exercisable from and after November 1, 2027; and 14,724 shares exercisable from and after November 1, 2028.
